Skip to content

Minimal Important Change of the Six-Minute Walk Distance in Patients with Esophageal Cancer Following Surgery

Minimal Important Change of the Six-Minute Walk Distance in Patients with Esophageal Cancer Following Surgery - Minimal Important Change of the Six-Minute Walk Distance in Patients with Esophageal Cancer Following Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000061561
Enrollment
67
Registered
2026-06-01
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

None listed

Sponsors

Nagasaki University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients diagnosed with esophageal cancer or esophagogastric junction cancer Patients aged 20 years or older at the time of informed consent Patients able to walk independently preoperatively Patients scheduled to undergo elective esophagectomy

Exclusion criteria

Exclusion criteria: Patients who underwent reoperation within 3 weeks after surgery Patients with comorbidities that could affect the 6-minute walk test (6MWT) (e.g., musculoskeletal or neurological disorders causing gait impairment, such as pain or impaired balance ability) Patients unable to understand the QLQ-C30 questionnaire due to visual or hearing impairment, or cognitive dysfunction Patients with missing data for the 6-minute walk distance and QLQ-C30 physical functioning score at both preoperative assessment and 3 weeks postoperatively

Design outcomes

Primary

MeasureTime frame
six-minute walk distance

Secondary

MeasureTime frame
European Organization for Research and Treatment of Cancer Quality of Life Questionnaire - C30

Countries

Japan

Contacts

Public ContactShusuke toyama

Nagasaki University Graduate School of Biomedical Sciences Department of Physical Therapy Science

hnsnore225@gmail.com095-819-7963

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026